embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results
Key Highlights
- ➤Embecta will report fiscal Q4 and full-year 2026 results November 24
- ➤Preliminary fiscal 2027 financial guidance will accompany the operational update
- ➤Conference call includes a question-and-answer session for investors
PARSIPPANY, N.J., Nov. 20, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal fourth quarter and full year 2026 financial results, provide an operational update, including preliminary fiscal year 2027 financial guidance, and host a question and answer session at 8:00 a.m. Eastern Time (ET) on Tuesday, November 24, 2026.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company's website at investors.embecta.com.
Get started
Create a free account to read the full story.
